First Bellwether Trial Over Nexium, Prilosec or Other PPI Kidney Risks Set to Begin in November 2021
The first trial over kidney problems involving the use of Nexium, Prilosec, and similar heartburn medications will begin in November 2021.…
The first trial over kidney problems involving the use of Nexium, Prilosec, and similar heartburn medications will begin in November 2021.…
In September 2019, the FDA warned that the popular heartburn drug Zantac may contain cancer-causing impurities. These same chemicals have been linked to an increased risk of colorectal cancer, stomach cancer, liver cancer and other health problems.…
A federal judge has laid out a plan for the selection of cases for bellwether trials over Nexium, Prilosec and other heartburn drug kidney injuries.…
All Nexium, Prilosec, and Prevacid kidney injury lawsuits filed in New Jersey have been consolidated before one judge for pretrial proceedings.…
Parties involved in Nexium, Prilosec and Prevacid kidney damage litigation will debate when bellwether trials should begin at a status conference this week.…
A class action lawsuits seeks compensation for the money plaintiffs spent on buying over-the-counter Zantac, without knowing it contained high levels of a potentially cancer-causing agent.…
Australian investigators say 75% of all Zantac tablets contain excessive amounts of NDMA, which is a suspected carcinogen.…
The initial petition warning of Zantac NDMA contamination calls for the drug to be recalled, special disposal instructions to prevent NDMA from contaminating the nation’s water supply, and new rules on how drugs are tested for chemical impurities.…
A Zantac recall announced by GlaxoSmithKline due to NDMA contamination affects all prescription-strength brand-name versions of the medication.…
The FDA says it has found “unacceptable” levels of NDMA in Zantac, even when using more forgiving testing procedures.…